Jasinska A, Pandrea I, Apetrei C
Front Immunol. 2022; 13:835994.
PMID: 35154162
PMC: 8829453.
DOI: 10.3389/fimmu.2022.835994.
Garg H, Joshi A
Viruses. 2017; 9(8).
PMID: 28829402
PMC: 5579491.
DOI: 10.3390/v9080237.
Skar H, Gutenkunst R, Ramsay K, Alaeus A, Albert J, Leitner T
PLoS One. 2011; 6(8):e21747.
PMID: 21829600
PMC: 3149046.
DOI: 10.1371/journal.pone.0021747.
Redd A, Laeyendecker O, Kong X, Kiwanuka N, Lutalo T, Huang W
AIDS Res Hum Retroviruses. 2011; 28(3):289-94.
PMID: 21663455
PMC: 3292754.
DOI: 10.1089/AID.2011.0006.
van Gils M, Edo-Matas D, Bowles E, Burger J, Stewart-Jones G, Schuitemaker H
J Virol. 2011; 85(16):8443-8.
PMID: 21653664
PMC: 3147988.
DOI: 10.1128/JVI.05214-11.
Clinical significance of HIV-1 coreceptor usage.
Schuitemaker H, van t Wout A, Lusso P
J Transl Med. 2011; 9 Suppl 1:S5.
PMID: 21284904
PMC: 3105505.
DOI: 10.1186/1479-5876-9-S1-S5.
R5X4 HIV-1 coreceptor use in primary target cells: implications for coreceptor entry blocking strategies.
Loftin L, Kienzle M, Yi Y, Collman R
J Transl Med. 2011; 9 Suppl 1:S3.
PMID: 21284902
PMC: 3105503.
DOI: 10.1186/1479-5876-9-S1-S3.
A novel CCR5 mutation common in sooty mangabeys reveals SIVsmm infection of CCR5-null natural hosts and efficient alternative coreceptor use in vivo.
Riddick N, Hermann E, Loftin L, Elliott S, Wey W, Cervasi B
PLoS Pathog. 2010; 6(8):e1001064.
PMID: 20865163
PMC: 2928783.
DOI: 10.1371/journal.ppat.1001064.
Constrained use of CCR5 on CD4+ lymphocytes by R5X4 HIV-1: efficiency of Env-CCR5 interactions and low CCR5 expression determine a range of restricted CCR5-mediated entry.
Loftin L, Kienzle M, Yi Y, Lee B, Lee F, Gray L
Virology. 2010; 402(1):135-48.
PMID: 20381825
PMC: 2872044.
DOI: 10.1016/j.virol.2010.03.009.
Comparison of human immunodeficiency virus type 1 tropism profiles in clinical samples by the Trofile and MT-2 assays.
Coakley E, Reeves J, Huang W, Mangas-Ruiz M, Maurer I, Harskamp A
Antimicrob Agents Chemother. 2009; 53(11):4686-93.
PMID: 19687240
PMC: 2772338.
DOI: 10.1128/AAC.00229-09.
Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization.
Ince W, Harrington P, Schnell G, Patel-Chhabra M, Burch C, Menezes P
J Virol. 2009; 83(9):4068-80.
PMID: 19211740
PMC: 2668457.
DOI: 10.1128/JVI.02486-08.
Evolution of CCR5 use before and during coreceptor switching.
Coetzer M, Nedellec R, Salkowitz J, McLaughlin S, Liu Y, Heath L
J Virol. 2008; 82(23):11758-66.
PMID: 18815295
PMC: 2583682.
DOI: 10.1128/JVI.01141-08.
Dendritic cells preferentially transfer CXCR4-using human immunodeficiency virus type 1 variants to CD4+ T lymphocytes in trans.
van Montfort T, Thomas A, Pollakis G, Paxton W
J Virol. 2008; 82(16):7886-96.
PMID: 18524826
PMC: 2519566.
DOI: 10.1128/JVI.00245-08.
Conserved changes in envelope function during human immunodeficiency virus type 1 coreceptor switching.
Pastore C, Nedellec R, Ramos A, Hartley O, Miamidian J, Reeves J
J Virol. 2007; 81(15):8165-79.
PMID: 17507486
PMC: 1951319.
DOI: 10.1128/JVI.02792-06.
Evolution of CXCR4-using human immunodeficiency virus type 1 SF162 is associated with two unique envelope mutations.
Kiselyeva Y, Nedellec R, Ramos A, Pastore C, Margolis L, Mosier D
J Virol. 2007; 81(7):3657-61.
PMID: 17202224
PMC: 1866070.
DOI: 10.1128/JVI.02310-06.
Increased neutralization sensitivity of recently emerged CXCR4-using human immunodeficiency virus type 1 strains compared to coexisting CCR5-using variants from the same patient.
Bunnik E, Quakkelaar E, van Nuenen A, Boeser-Nunnink B, Schuitemaker H
J Virol. 2006; 81(2):525-31.
PMID: 17079299
PMC: 1797458.
DOI: 10.1128/JVI.01983-06.
Differential susceptibility of naïve, central memory and effector memory T cells to dendritic cell-mediated HIV-1 transmission.
Groot F, van Capel T, Schuitemaker J, Berkhout B, de Jong E
Retrovirology. 2006; 3:52.
PMID: 16916447
PMC: 1562438.
DOI: 10.1186/1742-4690-3-52.
A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences.
Jensen M, Coetzer M, van t Wout A, Morris L, Mullins J
J Virol. 2006; 80(10):4698-704.
PMID: 16641263
PMC: 1472078.
DOI: 10.1128/JVI.80.10.4698-4704.2006.
Differences in the fitness of two diverse wild-type human immunodeficiency virus type 1 isolates are related to the efficiency of cell binding and entry.
Marozsan A, Moore D, Lobritz M, Fraundorf E, Abraha A, Reeves J
J Virol. 2005; 79(11):7121-34.
PMID: 15890952
PMC: 1112120.
DOI: 10.1128/JVI.79.11.7121-7134.2005.
CCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremia.
Blaak H, Boers P, Gruters R, Schuitemaker H, van der Ende M, Osterhaus A
J Virol. 2005; 79(3):1686-700.
PMID: 15650194
PMC: 544080.
DOI: 10.1128/JVI.79.3.1686-1700.2005.